PETX
Aratana Therapeutics, Inc.
PETX
PETX
Delisted
PETX was delisted on the 17th of July, 2019.
105 hedge funds and large institutions have $161M invested in Aratana Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
17% less capital invested
Capital invested by funds: $194M → $161M (-$33.7M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
105
Holding in Top 10
1
Calls
$123K
Puts
$44K
Top Buyers
| 1 | +$3.27M | |
| 2 | +$1.78M | |
| 3 | +$1.32M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.12M |
| 5 |
NSEDCP
NJ State Employees Deferred Compensation Plan
Trenton,
New Jersey
|
+$736K |
Top Sellers
| 1 | -$5.91M | |
| 2 | -$4.68M | |
| 3 | -$2.57M | |
| 4 |
TAM
Tocqueville Asset Management
New York
|
-$1.58M |
| 5 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$1.06M |